Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I

Authors

Sarah C Hurt, Washington University School of Medicine in St. Louis
Moin U Vera, Lundquist Institute at Harbor-UCLA Medical Center
Steven Q Le, Washington University School of Medicine in St. Louis
Shih-Hsin Kan, Lundquist Institute at Harbor-UCLA Medical Center
Quang Bui, Lundquist Institute at Harbor-UCLA Medical Center
Patricia I Dickson, Washington University School of Medicine in St. Louis

Journal

Molecular Genetics and Metabolism Reports

Publication Date

3-1-2024

Volume

38

First Page

101036

Document Type

Open Access Publication

DOI

10.1016/j.ymgmr.2023.101036

Rights and Permissions

Hurt SC, Vera MU, Le SQ, Kan SH, Bui Q, Dickson PI. Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I. Mol Genet Metab Rep. 2023 Dec 14;38:101036. doi: 10.1016/j.ymgmr.2023.101036. © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Hurt, Sarah C; Vera, Moin U; Le, Steven Q; Kan, Shih-Hsin; Bui, Quang; and Dickson, Patricia I, "Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I." Molecular Genetics and Metabolism Reports. 38, 101036 (2024).
https://digitalcommons.wustl.edu/oa_4/3776

Department

ICTS (Institute of Clinical and Translational Sciences)